Chunyu Xia

988 total citations
18 papers, 842 citations indexed

About

Chunyu Xia is a scholar working on Immunology, Biomedical Engineering and Oncology. According to data from OpenAlex, Chunyu Xia has authored 18 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 7 papers in Biomedical Engineering and 5 papers in Oncology. Recurrent topics in Chunyu Xia's work include Nanoplatforms for cancer theranostics (7 papers), Autophagy in Disease and Therapy (4 papers) and Synthesis of heterocyclic compounds (3 papers). Chunyu Xia is often cited by papers focused on Nanoplatforms for cancer theranostics (7 papers), Autophagy in Disease and Therapy (4 papers) and Synthesis of heterocyclic compounds (3 papers). Chunyu Xia collaborates with scholars based in China, Australia and United States. Chunyu Xia's co-authors include Zhirong Zhang, Qin He, Man Li, Yifei Li, Qun Liu, Xianxiu Xu, Xuhui Wang, Yang Long, Zhengze Lu and Jing Tan and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Chemical Communications.

In The Last Decade

Chunyu Xia

18 papers receiving 833 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunyu Xia China 15 306 299 208 195 176 18 842
Seungho Lim South Korea 14 392 1.3× 444 1.5× 273 1.3× 87 0.4× 140 0.8× 18 863
Andreas F. B. Räder Germany 11 509 1.7× 129 0.4× 139 0.7× 196 1.0× 67 0.4× 13 887
Lingyi Sun China 12 258 0.8× 106 0.4× 75 0.4× 81 0.4× 84 0.5× 34 659
Margit M. Janát‐Amsbury United States 16 365 1.2× 138 0.5× 202 1.0× 40 0.2× 109 0.6× 34 856
George Sharbeen Australia 14 385 1.3× 152 0.5× 123 0.6× 60 0.3× 76 0.4× 25 739
Jingxing Si China 14 297 1.0× 402 1.3× 292 1.4× 71 0.4× 93 0.5× 31 856
Lingpu Zhang China 11 237 0.8× 339 1.1× 176 0.8× 49 0.3× 100 0.6× 15 615
Rami W. Chakroun United States 12 430 1.4× 422 1.4× 592 2.8× 178 0.9× 111 0.6× 13 961

Countries citing papers authored by Chunyu Xia

Since Specialization
Citations

This map shows the geographic impact of Chunyu Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunyu Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunyu Xia more than expected).

Fields of papers citing papers by Chunyu Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunyu Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunyu Xia. The network helps show where Chunyu Xia may publish in the future.

Co-authorship network of co-authors of Chunyu Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Chunyu Xia. A scholar is included among the top collaborators of Chunyu Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunyu Xia. Chunyu Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
3.
Xu, Jian, Zhe Li, Xuequn Wang, & Chunyu Xia. (2022). Narrative information on secondhand products in e-commerce. Marketing Letters. 33(4). 625–644. 2 indexed citations
4.
Lu, Zhengze, Yang Long, Jiaxin Li, et al.. (2021). Simultaneous inhibition of breast cancer and its liver and lung metastasis by blocking inflammatory feed-forward loops. Journal of Controlled Release. 338. 662–679. 37 indexed citations
5.
Lu, Zhengze, Yang Long, Yashi Wang, et al.. (2021). Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immunosuppression. European Journal of Pharmaceutics and Biopharmaceutics. 165. 164–173. 36 indexed citations
6.
Xia, Chunyu, Man Li, Guang‐Yao Ran, et al.. (2021). Redox-responsive nanoassembly restrained myeloid-derived suppressor cells recruitment through autophagy-involved lactate dehydrogenase A silencing for enhanced cancer immunochemotherapy. Journal of Controlled Release. 335. 557–574. 35 indexed citations
7.
Deng, Miao, Rong Guo, Jingdong Rao, et al.. (2021). pH-Triggered Copper-Free Click Reaction-Mediated Micelle Aggregation for Enhanced Tumor Retention and Elevated Immuno–Chemotherapy against Melanoma. ACS Applied Materials & Interfaces. 13(15). 18033–18046. 25 indexed citations
8.
Wang, Xuhui, Man Li, Kebai Ren, et al.. (2020). On‐Demand Autophagy Cascade Amplification Nanoparticles Precisely Enhanced Oxaliplatin‐Induced Cancer Immunotherapy. Advanced Materials. 32(32). e2002160–e2002160. 105 indexed citations
9.
Rao, Jingdong, Ling Mei, Ji Liu, et al.. (2019). Size-adjustable micelles co-loaded with a chemotherapeutic agent and an autophagy inhibitor for enhancing cancer treatment via increased tumor retention. Acta Biomaterialia. 89. 300–312. 42 indexed citations
10.
Li, Man, Hanbing Xie, Yingke Liu, et al.. (2019). Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer. Journal of Controlled Release. 304. 204–215. 103 indexed citations
11.
Tang, Xian, Jingdong Rao, Sheng Yin, et al.. (2018). PD-L1 knockdown via hybrid micelle promotes paclitaxel induced Cancer-Immunity Cycle for melanoma treatment. European Journal of Pharmaceutical Sciences. 127. 161–174. 26 indexed citations
12.
13.
Yin, Sheng, Chunyu Xia, Yashi Wang, et al.. (2018). Dual receptor recognizing liposomes containing paclitaxel and hydroxychloroquine for primary and metastatic melanoma treatment via autophagy-dependent and independent pathways. Journal of Controlled Release. 288. 148–160. 51 indexed citations
14.
15.
Yi, Xiaoli, Jianxia Dong, Zhuoya Wan, et al.. (2015). Co-delivery of Pirarubicin and Paclitaxel by Human Serum Albumin Nanoparticles to Enhance Antitumor Effect and Reduce Systemic Toxicity in Breast Cancers. Molecular Pharmaceutics. 12(11). 4085–4098. 76 indexed citations
16.
Li, Yifei, Xianxiu Xu, Chunyu Xia, et al.. (2012). Double nucleophilic attack on isocyanide carbon: a synthetic strategy for 7-aza-tetrahydroindoles. Chemical Communications. 48(100). 12228–12228. 23 indexed citations
17.
Li, Yifei, Xianxiu Xu, Chunyu Xia, Ling Pan, & Qun Liu. (2012). Dithiolane‐Directed Tandem Oxidation/1,2‐Benzyl Migration of Tetramic Acids under Ambient Conditions. Advanced Synthesis & Catalysis. 354(9). 1712–1716. 8 indexed citations
18.
Li, Yifei, Xianxiu Xu, Jing Tan, et al.. (2011). Double Isocyanide Cyclization: A Synthetic Strategy for Two-Carbon-Tethered Pyrrole/Oxazole Pairs. Journal of the American Chemical Society. 133(6). 1775–1777. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seungho Lim Breakdown of academic impact, for papers by Andreas F. B. Räder Breakdown of academic impact, for papers by Lingyi Sun Breakdown of academic impact, for papers by Margit M. Janát‐Amsbury Breakdown of academic impact, for papers by George Sharbeen Breakdown of academic impact, for papers by Jingxing Si Breakdown of academic impact, for papers by Lingpu Zhang Breakdown of academic impact, for papers by Rami W. Chakroun
Rankless by CCL
2026